Methylprednisolone Acetate

Modified on 2009/10/14 21:49 by admin
Methylprednisolone acetate is a corticosteroid mainly indicated for the treatment of inflamed areas of the body. The medication may, however, be prescribed for a number of disorders, including rheumatic, endocrine, collagen, dermatologic, allergic, opthalmic, gastrointestinal, respiratory, hematologic and neoplastic diseases. Medications such as methylprednisolone acetate are given to replace a lack of cortisone-like hormones naturally produced by the body. Methylprednisolone acetate was approved by the U.S. Food and Drug Administration (FDA) in 1960.

On September 16, 2002, Urgent Care Pharmacy of Spartanburg, South Carolina recalled all lots of its injectable methylprednisolone acetate based on reports of four patients who developed a rare fungal (wangiella) meningitis (a life threatening infection of the lining of the brain and spinal cord) after use of their product. These patients were treated at three different North Carolina hospitals/clinics. Spinal fluid from all of these patients tested positive for a fungus consistent with that found in the Urgent Care product analyzed by both the FDA and Centers for Disease Control and Prevention (CDC). One patient later died despite antifungal therapy. Urgent Care distributed the medication to physicians, hospitals, clinics and consumers in Connecticut, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Mississippi, New Hampshire, North Carolina, South Carolina and Virginia.

See your doctor if you have experienced serious health problems after taking methylprednisolone acetate. In addition, it may be important to contact a lawyer who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Corticosteroids
  2. Balance Problems: Overview
  3. Bladder Control & Urination Problems: Overview
  4. Eye Disorders
  5. Joints & Muscles: Overview
  6. Skin Disorders: Overview
  Name Size